You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 17, 2025

Drug Price Trends for HEALTHYLAX POWDER PACKET


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for HEALTHYLAX POWDER PACKET

Average Pharmacy Cost for HEALTHYLAX POWDER PACKET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
HEALTHYLAX POWDER PACKET 60687-0431-92 1.20656 EACH 2025-01-22
HEALTHYLAX POWDER PACKET 60687-0431-99 1.20656 EACH 2025-01-22
HEALTHYLAX POWDER PACKET 60687-0431-98 1.20656 EACH 2025-01-22
HEALTHYLAX POWDER PACKET 60687-0431-27 1.20656 EACH 2025-01-22
HEALTHYLAX POWDER PACKET 60687-0431-92 1.17671 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Healthylax Powder Packet

Overview of Healthylax

Healthylax is a laxative product that contains Polyethylene Glycol 3350 (PEG 3350) as its active ingredient. It is designed to relieve occasional constipation by softening the stool and promoting a bowel movement within 2 to 4 days[1].

Market Demand and Trends

The demand for polyethylene glycol 3350 products, including Healthylax, has been significant and is expected to continue growing.

Pharmaceutical and Personal Care Industries

The polyethylene glycol market, which includes PEG 3350, is projected to grow from USD 3.94 billion in 2024 to USD 5.31 billion by 2029, at a CAGR of 6.2%. This growth is driven by increasing demand in the pharmaceutical and personal care industries. PEG is widely used as a solvent, stabilizer, and binder in drug formulations, enhancing the solubility and bioavailability of drugs[3].

Regional Growth

The Asia Pacific region is expected to be the fastest-growing market for PEG due to the rapid expansion of the pharmaceutical and healthcare industries, particularly in countries like India and China. This region's growing consumer awareness and increasing disposable income also contribute to the rising demand for PEG in skincare and beauty products[3].

Sales and Prescription Data

Historical Sales

Sales data for polyethylene glycol 3350 products show a significant shift from prescription to over-the-counter (OTC) status. Between 2007 and 2011, prescription sales of PEG 3350 products decreased by 46%, while OTC sales increased by 124%. In 2011, approximately 10.4 million prescriptions were dispensed for PEG 3350 products, with MiraLAX and its generic equivalents accounting for the largest proportion[4].

Pediatric and Adult Usage

In the pediatric population (ages 0-16), MiraLAX and its generic equivalents dominated the market, accounting for nearly all prescriptions dispensed. For adults, the usage of PEG 3350 products also saw a significant increase, with 89.3 million prescriptions dispensed between 2002 and 2011[4].

Price Analysis

Current Pricing

The current price for Healthylax powder packets can vary depending on the retailer and location. However, as of recent data, a packet of Healthylax can cost around $16.95[5].

Price Projections

Given the growing demand and expanding market for PEG 3350 products, prices may remain stable or see a slight increase. Here are some factors that could influence price projections:

  • Raw Material Costs: Any increase in the cost of raw materials, such as polyethylene glycol, could lead to higher production costs and potentially higher prices for the final product.
  • Market Competition: The presence of generic equivalents and other brands could keep prices competitive. However, brand loyalty and the reputation of Healthylax might allow for some price flexibility.
  • Regulatory Factors: Changes in regulatory policies or healthcare reimbursement rates could impact the pricing strategy of manufacturers.
  • Economic Conditions: Economic factors such as inflation, consumer spending power, and global economic trends can also influence pricing.

Key Drivers of Market Growth

Increasing Demand in End-Use Industries

The pharmaceutical and personal care industries are driving the demand for PEG 3350. The growing awareness of product efficacy and safety in cosmetics and skincare products has led to an increased use of PEG in these sectors[3].

Government Policies and Industrial Growth

Government policies supporting industrial growth, particularly in regions with a strong industrial base like North America, contribute to the market growth of PEG 3350 products[3].

Research and Development

Investments in research and development for producing high-quality and cost-effective PEG products can help manufacturers strengthen their market position. The rise of biologics and personalized medicines also presents opportunities for advanced PEG formulations[3].

Challenges and Opportunities

Sustainability and Bio-Based PEG

The increasing inclination towards sustainability creates an opportunity for manufacturing bio-based PEG, which could attract environmentally conscious consumers. This trend could influence pricing and market positioning[3].

Competition from Generic Equivalents

The presence of generic equivalents can keep prices competitive, but it also presents an opportunity for Healthylax to differentiate itself through branding, quality, and customer service.

Conclusion

The market for Healthylax and other PEG 3350 products is expected to grow due to increasing demand in the pharmaceutical and personal care industries. While prices may remain competitive due to the presence of generic equivalents, factors such as raw material costs, market competition, and regulatory policies will influence price projections.

Key Takeaways

  • Growing Market Demand: The polyethylene glycol market is projected to grow significantly by 2029.
  • Regional Growth: The Asia Pacific region is expected to be a key driver of this growth.
  • Price Stability: Prices are likely to remain stable or see a slight increase due to market competition and economic factors.
  • Sustainability Trends: The shift towards bio-based PEG could influence market positioning and pricing.
  • Research and Development: Investments in R&D are crucial for maintaining market position and exploring new applications.

FAQs

1. What is the active ingredient in Healthylax? The active ingredient in Healthylax is Polyethylene Glycol 3350 (PEG 3350)[1].

2. How does Healthylax work? Healthylax works by softening the stool and promoting a bowel movement within 2 to 4 days[1].

3. What is the projected growth of the polyethylene glycol market? The polyethylene glycol market is projected to grow from USD 3.94 billion in 2024 to USD 5.31 billion by 2029, at a CAGR of 6.2%[3].

4. Which regions are driving the growth of the PEG market? The Asia Pacific region, particularly countries like India and China, is driving the growth of the PEG market due to rapid expansion in the pharmaceutical and healthcare industries[3].

5. How has the sales trend for PEG 3350 products changed over the years? Between 2007 and 2011, prescription sales of PEG 3350 products decreased by 46%, while OTC sales increased by 124%[4].

Sources

  1. Drugs.com: Healthylax (powder, for solution) American Health Packaging.
  2. Nemours Children's Health: NCH-DE Procedures and Supplies.
  3. GlobeNewswire: Polyethylene Glycol Market Estimated to Reach $5.31 billion by 2029.
  4. FDA: Sales Distribution Data for Polyethylene Glycol 3350 Products.
  5. Drugs.com: Healthylax Prices, Coupons, Copay Cards & Patient Assistance.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.